A recent study revealed that the effector function of CD8+CD27+CXCR3−T cells is overactive in active SLE compared with healthy controls and patients in remission, and this overactivity is positively associated with clinical SLE activity (60). This evidence concerns the gene CD27 and systemic lupus erythematosus.